Search results
Feb 3, 2021 · Janet Woodcock — often referred to as “the top drug cop” — had been in charge of CEDR for only a year in 1995 when the FDA considered approving OxyContin for sale to the public. Purdue ...
Jun 15, 2022 · Celine Castronuovo. A top FDA official who oversaw the approval of Purdue Pharma ‘s OxyContin said Wednesday that the agency failed to adequately predict the harms associated with the drug that has fallen into the center of the US opioid epidemic. Janet Woodcock, now the Food and Drug Administration’s principal deputy commissioner, said in ...
- ccastronuovo@bloombergindustry.com
- Reporter
Feb 23, 2021 · Ed Bisch, whose 18-year-old son, Eddie, died of an OxyContin-related overdose in 2001. Credit... Hannah Yoon for The New York Times. Share full article. ... Dr. Janet Woodcock, long known as the ...
2020 Letter to U.S. Senate: FDA Director of Center for Drug Evaluation & Research (now FDA Acting Commissioner) Janet Woodcock Stands by Approval of OxyContin Since 1995. In the United States, the Food and Drug Administration has sole responsibility and authority for approving prescription (Rx) medications.
Jan 28, 2021 · Dr Janet Woodcock is accused of presiding over ‘one of the worst regulatory agency failures’, say groups fighting opioid epidemic Chris McGreal Thu 28 Jan 2021 12.18 EST Last modified on Thu ...
Feb 4, 2021 · Janet Woodcock is acting head of the FDA, ... controversial decisions undertaken during Dr Woodcock’s first period as head of the CDER was the 1995 approval of OxyContin, the powerful ...
Janet Woodcock. Janet Woodcock (born August 29, 1948) is an American physician serving as Principal Deputy Commissioner of Food and Drugs, having previously served as Acting Commissioner of the U.S. Food and Drug Administration (FDA). [2] She joined the FDA in 1986, and has held a number of senior leadership positions there, including terms as ...
